BioSpace News Archive

TC BioPharm Limited, a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications announced that Executive Chairman and Founder, Dr. Michael Leek will be participating in Advanced Therapies Week in Miami, Florida January 25-28.

nference, an AI-driven health technology company, today announced the publication of a preprint study in medRxiv, validating the company’s methodology for characterizing SARS-CoV-2 evolution.

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the huNOG-EXL EA (Early Access) humanized immune system (HIS) mouse.

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of a case series in the journal Cardiovascular Revascularization Medicine describing successful uses of the Neovasc Reducer™ (“Reducer”) under a compassionate use protocol in the United States.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a PHASE 2A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF INTRAVENOUS ALLOGENEIC ADIPOSE-DERIVED MESENCHYMAL STROMAL CELLS TO TREAT POST COVID-19 “LONG HAUL” PULMONARY COMPROMISE (NCT04992247).

Clarius Mobile Health introduced its third-generation product line of high-performance handheld wireless ultrasound scanners for veterinarians.

Neuropathix, Inc., a socially responsible pain management life sciences company, announces that the Company has been issued Indian Patent IN201617027528 specific to its global patent known as WO2015/106108A2 titled, “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy”.

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction -based DNA manufacturing and nucleic acid-based technologies, announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, has seen COVID-19 testing levels increase greater than 90% for the quarter ended December 31, 2021, compared to the fiscal quarter ended September 30, 2021.

Aromyx, a leading company in applying biotechnology and data science to capture unique sensory data, announced that retail and Consumer Packaged Goods consumer insights expert, Elise Kern, has joined the company as SVP of Data and Insights.

PreOmics Offers Unique Technologies, Advanced Automation Solutions and High-Performance Consumables for the Homogenization, Enrichment and Sample Preparation of Biopsy, Tissue, Cell Line and Plasma Samples in Unbiased, Deep Proteomics for Biopharma and Clinical Research.